Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Cutera, Inc.
  6. News
  7. Summary
    CUTR   US2321091082

CUTERA, INC.

(CUTR)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Cutera : Earnings Flash (CUTR) CUTERA Posts Q2 Revenue $58.6M, vs. Street Est of $50.2M

08/04/2021 | 04:12pm EST


ę MT Newswires 2021
All news about CUTERA, INC.
12/01Cutera Launches Next Gen Rapid Muscle Sculpting with truSculpt« flex+
PR
12/01Cutera Launches Next Gen Rapid Muscle Sculpting with truSculpt? Flex+
CI
11/23Cutera, Inc. to Participate in the Piper Sandler Virtual Healthcare Conference
BU
11/10Cutera, Inc. to Participate in a Virtual Fireside Chat at the Stifel Healthcare Confere..
BU
11/08Canadian Dermatology and Plastic Surgery Centre Adds Secret PRO by Cutera, Inc. for Tot..
CI
11/05NORTH AMERICAN MORNING BRIEFING : Stock Futures -3-
DJ
11/04CUTERA INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF ..
AQ
11/04Maxim Group Upgrades Cutera to Buy From Hold; Price Target is $60
MT
11/03Cutera Q3 Results Rise to Exceed Expectations, Raises Revenue Guidance -- Stock Up 2% A..
MT
11/03CUTERA : Q3 Earnings Snapshot
AQ
More news
Analyst Recommendations on CUTERA, INC.
More recommendations
Financials (USD)
Sales 2021 226 M - -
Net income 2021 6,69 M - -
Net Debt 2021 - - -
P/E ratio 2021 137x
Yield 2021 -
Capitalization 714 M 714 M -
Capi. / Sales 2021 3,16x
Capi. / Sales 2022 2,89x
Nbr of Employees 323
Free-Float 97,2%
Chart CUTERA, INC.
Duration : Period :
Cutera, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CUTERA, INC.
Short TermMid-TermLong Term
TrendsNeutralBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 5
Last Close Price 39,79 $
Average target price 63,40 $
Spread / Average Target 59,3%
EPS Revisions
Managers and Directors
David H. Mowry Chief Executive Officer & Director
Rohan Seth Chief Financial Officer
James Daniel Plants Executive Chairman
Michael Karavitis Chief Technology Officer & Executive VP
Timothy J. OĺShea Independent Director
Sector and Competitors
1st jan.Capi. (M$)
CUTERA, INC.65.04%714
THERMO FISHER SCIENTIFIC37.01%251 462
DANAHER CORPORATION41.06%227 421
INTUITIVE SURGICAL, INC.24.97%121 746
SIEMENS HEALTHINEERS AG59.17%84 955
EDWARDS LIFESCIENCES CORPORATION30.94%74 583